School of Medicine
Showing 1-33 of 33 Results
-
Muhammad Abdelbasset Muhammad Ahmad
Postdoctoral Scholar, Infectious Diseases
BioPostdoctoral fellow, Department of Medicine, Stanford University (2022– Present).
PhD, Duke-National University of Singapore (2017 – 2021).
MSc, Faculty of Pharmacy, Cairo University (2014 – 2016).
BSc, Faculty of Pharmacy, Cairo University (2007 – 2012). -
Ronan Arthur
Postdoctoral Scholar, Infectious Diseases
BioRonan Arthur (PhD) is a postdoctoral scholar in the Stanford School of Medicine. Ronan studies TB preventive therapy, adaptive behavior and community trust during epidemics through mathematical modeling techniques and empirical work in Liberia. Current research includes: hospital hand hygiene in Liberia; hospital ventilation in rural Liberia; adaptive behavior during epidemics with age-structure; quantifying gene-culture co-evolution; trust of government and health system during COVID-19 in Liberia; and agent-based modeling of COVID-19 and Ebola Virus Disease.
-
Florian Bach
Postdoctoral Scholar, Infectious Diseases
BioI'm a molecular infection biologist by training, but shifted my focus from pathogens to hosts for my graduate research. During my PhD with Phil Spence in Edinburgh I studied both falciparum and vivax malaria using controlled human (re)infection models, collaborating closely with the groups of Simon Draper and Angela Minassian in Oxford. As a hybrid bioinformatician and experimentalist, I love systems immunology for answering complex questions about human health. For my postdoc, I study in how the human immune response to malaria evolves in infants as they become reinfected and age. I'm also interested in how such early-life immunological events, malaria and beyond, may affect vaccine responses and immune development later in life. I address this question by making use of a longitudinal study cohort of infants receiving monthly chemoprevention in Eastern Uganda, together with our collaborators at UC San Francisco and IDRC Uganda.
-
Jessica Grembi
Postdoctoral Scholar, Infectious Diseases
BioEnvironmental enteric dysfunction (EED) affects 50-90% of children in low-income countries and is likely an important factor in child stunting as it impedes efficient nutrient uptake in the small intestine. EED is suspected to be the result of persistent exposure to enteric pathogens, although it has not been correlated with any specific pathogen. My research explores the interplay of gut microbiota, including enteric pathogens, and the host immune system with a focus on understanding EED so we can rationally design treatments and preventive measures.
-
Abraar Karan, MD MS MPH DTM&H
Postdoctoral Medical Fellow, Infectious Diseases
Fellow in Medicine - Med/Infectious DiseasesBioI am an infectious disease fellow and post-doctoral researcher in the Division of Infectious Diseases and Geographic Medicine, the Luby Lab, the Center for Innovation in Global Health, the King Center on Global Development, and the Woods Institute for the Environment. I worked on the Covid19 outbreak for the Massachusetts Department of Public Health in 2020, and the Monkeypox outbreak for the Los Angeles County Department of Public Health in 2022-23. I also served on the WHO-commissioned Independent Panel on Pandemic Preparedness and Response's research team investigating early global spread of Covid19, and helped with policy-writing for the Biden-Harris campaign on reducing Covid19 in schools. I am currently the Principal Investigator of the following studies: a cluster-randomized controlled trial investigating whether air filtration and ventilation can reduce spread of Covid19 in low-income homes in the Bay Area (https://clinicaltrials.gov/ct2/show/NCT05777720); piloting a low-cost rural surveillance system for detecting spillover of zoonotic diseases in Western Kenya.
I completed my internal medicine residency at the Brigham and Women's Hospital/Harvard Medical School in the Global Health Equity program, and have been working in global health since 2008. I co-edited the book, "Protecting the Health of the Poor" (December 2015, Bloomsbury Publishing, https://www.bloomsbury.com/us/protecting-the-health-of-the-poor-9781783605521/); and co-founded Longsleeve insect repellent, winner of the 2018 Harvard Business School New Venture Competition and finalist in the 2019 Harvard President's Challenge. Media/press coverage has included NBC, ABC, BBC, PBS, CBS, CNN, MSNBC, Fox News, Washington Post, New York Times, SF Chronicle, Bloomberg, Boston Globe, ProPublica, WSJ, TIME, Politico, CBC News, Democracy Now, NPR, ESPN, The Atlantic, The Hill, Business Insider, Vice, Mother Jones, Vox, Forbes, Slate, STAT News, MTV News, Mother Jones, Science Friday, TMZ.
For a full list of publications, please see "Publications" tab. For full list of press/media interviews, please see "Media" link.
Teaching Experience:
Teaching Assistant-- Epi 231, Infectious Disease Epidemology (Winter 2024)
Teaching Assistant-- Epi 237, Practical Approaches to Global Health Research (Autumn 2024) -
Max Lamparth
Postdoctoral Scholar, Infectious Diseases
BioMax is a postdoctoral fellow at the Center for International Security and Cooperation, the Stanford Center for AI Safety, the Stanford Existential Risks Initiative, and the Brainstorm Lab at the Department of Psychiatry and Behavioral Sciences at Stanford University. He is advised by Prof. Clark Barrett, Prof. Steve Luby, and Prof. Paul Edwards.
With his research, he wants to make AI systems more secure and safe to use. Specifically, he is focussing on improving the ethical behavior of language models, making their inner workings more interpretable, and increasing their robustness against misuse.
Max received his Ph.D. in August 2023 from the School of Natural Sciences at the Technical University of Munich and previously a B.Sc. and M.Sc. in Physics from the Ruprecht Karl University of Heidelberg. -
Yimam Misganie
Postdoctoral Scholar, Infectious Diseases
Current Research and Scholarly InterestsDr. Misganie's research focuses on AI-driven analysis of complex datasets, particularly in viral infections like HIV drug resistance (HIVDR). He use AI and machine learning to understand viral dynamics, drug resistance mechanisms, and treatment outcomes. His work integrates big data and genomic data to inform public health strategies. He also study viral molecular epidemiology using whole-genome sequencing and apply NLP techniques to enhance research in global health.
-
Ruoxi Pi
Postdoctoral Scholar, Infectious Diseases
BioI received my BS in Biological Sciences in Zhejiang University in China, where I conducted research in polyphasic taxonomy in anaerobic bacteria. I received my PhD in Yale University, where I studied the early events of retrovirus infection in animal models. Now in the Blish lab, I am investigating NK cell responses during HIV-1 infection and trying to manipulate the NK cells to target latently infected cells.
-
Erika Viana Cardenas
Postdoctoral Scholar, Infectious Diseases
BioMedical Doctor passionate for public health and evidence-based decision making with experience in data analysis and surveillance systems in the Colombian government sector and academic research.
-
Whitney Weber
Postdoctoral Scholar, Infectious Diseases
BioWhitney is a postdoctoral scholar in the laboratory of Dr. Joelle Rosser at Stanford University investigating the impacts of climate change on arbovirus infection acquisition in a mother-child human cohort in Indonesia. She recently completed her PhD in 2024 focused in viral immunology in the laboratory of Dr. Daniel Streblow at Oregon Health and Science University. She has 4+ years of experience focused in antibody-mediated immunity to emerging pathogenic alphaviruses. Her dissertation research focused on characterizing cross-reactive immunity in the context of alphavirus infection and vaccination in an effort to develop cross-protective alphavirus vaccines. Her post-bacc work included 2+ years of research experience in HIV immunology studying the mechanism of HIV cure and evaluating therapeutics in NHP. Her long-term research and career interests are rooted in studying the mechanisms of viral emergence, viral surveillance and seroprevalence in various hosts, identifying cross-reactive immune responses, and developing multivalent vaccine approaches for emerging viruses.
-
Yasuaki Yanagawa
Postdoctoral Scholar, Infectious Diseases
BioRNAseq for Entaoeba histolytica